Growth N V Biotech Black Diamond Therapeutics, Inc. (BDTX) insider trading activity

Growth N V Biotech is > 10% Shareholder of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 2.73 Million shares of BDTX, which is worth approximately $4.26 Million. The most recent transaction as insider was on Mar 19, 2025, when has been sold 5,784,292 shares (Common Stock) at a price of $2.07 per share, resulting in proceeds of $11,973,484. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.73M

67.91% 3M change

67.91% 12M change

Total Value Held $4.26 Million

GROWTH N V BIOTECH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 19 2025	SELL Open market or private sale	$11,973,484 $2.07 p/Share	5,784,292 Reduced 67.91%	2,733,547 Common Stock
Oct 17 2023	BUY Open market or private purchase	$936,000 $2.34 p/Share	400,000 Added 4.49%	8,517,839 Common Stock
Jun 30 2023	BUY Open market or private purchase	$5,000,000 $5.0 p/Share	1,000,000 Added 10.97%	8,117,839 Common Stock
Jun 27 2023	BUY Open market or private purchase	$9,552,600 $5.49 p/Share	1,740,000 Added 19.64%	7,117,839 Common Stock
Oct 31 2022	BUY Open market or private purchase	$224,552 $2.25 p/Share	99,801 Added 1.82%	5,377,839 Common Stock
Oct 28 2022	BUY Open market or private purchase	$377,083 $2.18 p/Share	172,974 Added 3.17%	5,278,038 Common Stock
Oct 27 2022	BUY Open market or private purchase	$358,438 $1.87 p/Share	191,678 Added 3.62%	5,105,064 Common Stock
Oct 21 2022	BUY Open market or private purchase	$132,653 $1.51 p/Share	87,850 Added 1.76%	4,913,386 Common Stock
Oct 20 2022	BUY Open market or private purchase	$76,302 $1.42 p/Share	53,734 Added 1.1%	4,825,536 Common Stock
Oct 19 2022	BUY Open market or private purchase	$102,549 $1.32 p/Share	77,689 Added 1.6%	4,771,802 Common Stock
Apr 28 2022	BUY Open market or private purchase	$657,177 $2.57 p/Share	255,711 Added 5.17%	4,694,113 Common Stock
Apr 27 2022	BUY Open market or private purchase	$399,000 $2.66 p/Share	150,000 Added 3.27%	4,438,402 Common Stock
Apr 19 2022	BUY Open market or private purchase	$486,000 $3.24 p/Share	150,000 Added 3.38%	4,288,402 Common Stock
Apr 18 2022	BUY Open market or private purchase	$493,500 $3.29 p/Share	150,000 Added 3.5%	4,138,402 Common Stock
Apr 13 2022	BUY Open market or private purchase	$366,125 $3.57 p/Share	102,556 Added 2.51%	3,988,402 Common Stock
Apr 12 2022	BUY Open market or private purchase	$513,000 $3.42 p/Share	150,000 Added 3.72%	3,885,846 Common Stock

Also insider at

EPIX

ESSA Pharma Inc. Healthcare

GNV